The results showed that 2-aminoethoxy diphenyl borate significantly counteracted loss of cell viability in response to MPP+ as well as nearly totally preventing the increase in cytosolic Ca2+, similar to overexpression of mitochondrial PRDX5. Thus, mitochondrial PRDX5 is revealed as a viable target for neuroprotection through its ability to control ROS/reactive nitrogen species generation as well as Ca2+ dysregulation. The results of De Simoni and colleagues (De Simoni et al. 2013 ) fit within the interesting growing field of peroxiredoxins being regulators of dopaminergic degeneration in Parkinson's disease (PD). Thus, a role for peroxiredoxin in this disorder has been suggested to involve phosphorylation of the PRDX2 isoform in nigral neurons in post-mortem tissue from PD patients (Qu et al. 2007 ). PRDX1 over-expression protects against 6-hydroxydopamine (6-OHDA)-induced Parkinsonism in cell culture models (Lee et al. 2006) . Interestingly, the relatively low levels of PRDX5 in dopaminergic neurons may be an important reason why these neurons are less resistant to toxic stress than other neurons in the brain. Likewise, these findings raise a number of interesting possibilities. For example, follow-up experiments should now focus on the ability of PRDX5 to prevent neurotoxicity in both primary neurons and in PD-patient-specific iPS-derived dopaminergic neurons. Overall, the fact that PRDX5 clearly affects Ca2+ dynamics is also important in the light of the new anti-Parkinsonian therapeutics that regulate Ca2+ transport. The further involvement of PRDX5 in regulating Ca2+ dynamics in dopaminergic neurons remains to be seen. A number of tantalizing implications come to mind in light of recent research on mitochondrial transport and Ca2+ dynamics in the neuron. The recent focus on mitochondrial fusion and fission events, and interactions with the ER has opened up an exciting area of neuronal biology. The fact that PRDX5 controls redox signalling in the mitochondrion and Ca2+ dynamics suggests it may have a role in post-translation modification of key mitochondrial fusion/fission and transport proteins. The effect of mitochondrial PRDX5 on complex I activity must be clarified as this defect of the ETC is an important observation in idiopathic PD (Schapira et al. 1989) ; the possibility that PRDX5-related redox signalling may control individual complex I subunit activity might be relevant to the disease pathology. Finally, mitochondrial heterogeneity within neurons and other cell types in the brain may relate to PRDX5 subcellular distribution. Mitochondria that reside in the nerve terminal region in the pre-synaptic neuron are known to have lower complex I energy thresholds than mitochondria from other origin (Telford et al. 2009) , and seem to be more susceptible to neurotoxin-induced damage. Therefore, it would be interesting to analyse such mitochondria for the abundance of PRDX5 and other peroxiredoxins.
